The outcomes statement from the August special PBAC meeting reveals the committee largely sticking with the current approach and defaulting to the ongoing discussions on proposed submission process changes. …
Latest Video
New Stories
-
Bayer makes another move into cell therapy
August 22, 2019 - - Latest News -
Government could come for more given savings shortfall
August 22, 2019 - - Latest News -
Patients might be hoping their medicine belongs to a large company
August 22, 2019 - - Latest News -
Pfizer to invest US$500m in gene therapy manufacturing
August 22, 2019 - - Latest News -
FDA rejects Sarepta's second RNA therapy
August 21, 2019 - - Latest News -
PAGE co-founders on 'opening the door' to discussions on diversity
August 21, 2019 - - Latest News -
Biogen backs new learning resource
August 21, 2019 - - Latest News